Path Grand Rounds: A Tissue Assay of Drug Resistance: Androgen Receptor Variants in Prostate Cancer

This event has ended.


Larry True, MD and Elahe Mostaghel, MD, PhD
Multiple Departments
University of Washington

Date & Time

February 4, 2015 at 12:00pm - 1:00pm


UWMC, NE110 conference room


Why Attend?

To learn from a pathologist and clinician/molecular biologist how to develop a tissue-based immunohistochemical assay for use in deciding what drug to give a patient with metastatic cancer. We shall discuss the design and validation of IHC assays for androgen receptor v7 as a potential predictor of non-response to androgen deprivation therapy.

Larry True, MD
Professor, Department of Pathology
University of Washington

Elahe Mostaghel, MD, PhD
Associate Member, Clinical Research Division
Fred Hutchinson Cancer Research Center
Associate Professor, Medical Oncology
University of Washington

Reference: PMID: 25184630